COVID-19 & High Velocity Therapy: What we've learned so far
Kirk Hinkley presents "COVID-19 & High Velocity Therapy - What We've Learned So Far." In this course, you will:
Review COVID-19 symptoms, transmission, and mortality rate
- Discuss treatment approaches of respiratory distress associated with COVID-19
- Identify transmission precautions that can be taken for patients on high velocity therapy
- Understand implications of high velocity therapy for COPD comorbidities in COVID-19 patients
Overview additional roles of high velocity therapy for patient management
This course is AARC accredited for 1 CRCE under the Clinical Practice (CLP) category.
Dr. Hinkley has been a board-certified Emergency Medicine Physician for over 11 years. He is the Emergency Medicine Medical Director of Commonwealth Health EMS, where he maintains clinical oversight of several EMS units, and he practices as an Emergency Physician in Scranton, PA. Dr. Hinkley is also the Director of Emergency Department Education at Vapotherm. He went to medical school on a United States Air Force Scholarship and served in Operations Iraqi Freedom and Enduring Freedom as a critical care air transport team leader and flight surgeon. Dr. Hinkley is an experienced user of Vapotherm high velocity therapy.